In the last 12 months, insiders at Oncology Institute, Inc. ($TOI) filed 201 transactions with the SEC: 37 open-market purchases totaling $3,796,431 and 23 sales totaling $34,769,951. Net insider sentiment: net selling.
Oncology Institute, Inc. operates in the Services-offices & clinics of doctors of medicine industry (Industrial Applications and Services sector).
Most Active Insiders
- M33 Growth I L.P. (Director) — 11 transactions totaling $31,246,493
- Hively Brad (Director) — 33 transactions totaling $7,970,412
- BARASCH RICHARD A (Director) — 20 transactions totaling $3,070,025
- Chernett Jorey (TenPercentOwner) — 7 transactions totaling $1,936,290
- Virnich Daniel (Chief Executive Officer) — 19 transactions totaling $460,682
View all SEC Filings for Oncology Institute, Inc. (TOI).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 27, 2026 | Carter Robert Ross | Chief Financial Officer | J | Common Stock | 20320 | $3.07 | 416,405.0000 | 99,303,511 | 4.65% | 0.02% |
| March 27, 2026 | Langsam Jeffrey | Chief Clinical Officer | A | Common Stock | 70270 | $0.00 | 127,650.0000 | 99,303,511 | 122.46% | 0.07% |
| March 27, 2026 | England Kristin | Chief Administrative Officer | A | Common Stock | 55743 | $0.00 | 153,780.0000 | 99,303,511 | 56.86% | 0.06% |
| March 27, 2026 | Podnos Yale | Chief Medical Officer | A | Common Stock | 66446 | $0.00 | 300,956.0000 | 99,303,511 | 28.33% | 0.07% |
| March 27, 2026 | Podnos Yale | Chief Medical Officer | J | Common Stock | 16173 | $3.07 | 284,783.0000 | 99,303,511 | 5.37% | 0.02% |
| March 27, 2026 | Virnich Daniel | Chief Executive Officer | J | Common Stock | 98534 | $3.07 | 2,360,224.0000 | 99,303,511 | 4.01% | 0.10% |
| March 27, 2026 | Carter Robert Ross | Chief Financial Officer | A | Common Stock | 202914 | $0.00 | 436,725.0000 | 99,303,511 | 31.72% | 0.20% |
| March 27, 2026 | Virnich Daniel | Chief Executive Officer | A | Common Stock | 670608 | $0.00 | 2,458,758.0000 | 99,303,511 | 21.43% | 0.68% |
| March 27, 2026 | Chernett Jorey | TenPercentOwner | P | Common Stock | 27429 | $2.96 | 10,479,358.0000 | 99,303,511 | 0.26% | 0.03% |
| March 26, 2026 | Chernett Jorey | TenPercentOwner | P | Common Stock | 50000 | $3.15 | 10,451,929.0000 | 99,303,511 | 0.48% | 0.05% |
| March 24, 2026 | Chernett Jorey | TenPercentOwner | P | Common Stock | 125000 | $3.11 | 10,401,929.0000 | 99,303,511 | 1.22% | 0.13% |
| March 20, 2026 | Chernett Jorey | TenPercentOwner | P | Common Stock | 25000 | $3.35 | 10,276,929.0000 | 99,303,511 | 0.24% | 0.03% |
| March 17, 2026 | Podnos Yale | Chief Medical Officer | J | Common Stock | 3420 | $3.59 | 234,510.0000 | 99,303,511 | 1.44% | 0.00% |
| March 17, 2026 | Carter Robert Ross | Chief Financial Officer | J | Common Stock | 1314 | $3.59 | 233,811.0000 | 99,303,511 | 0.56% | 0.00% |
| March 17, 2026 | Virnich Daniel | Chief Executive Officer | J | Common Stock | 11834 | $3.59 | 1,788,150.0000 | 99,303,511 | 0.66% | 0.01% |
| March 13, 2026 | Chernett Jorey | TenPercentOwner | P | Common Stock | 263000 | $2.92 | 10,115,944.0000 | 99,303,511 | 2.67% | 0.26% |
| March 17, 2026 | Chernett Jorey | TenPercentOwner | P | Common Stock | 75000 | $3.42 | 10,251,929.0000 | 99,303,511 | 0.74% | 0.08% |
| March 16, 2026 | Chernett Jorey | TenPercentOwner | P | Common Stock | 60985 | $3.29 | 10,176,929.0000 | 99,303,511 | 0.60% | 0.06% |
| Jan. 2, 2026 | Carter Robert Ross | Chief Financial Officer | J | Common Stock | 244 | $3.67 | 235,125.0000 | 99,303,511 | 0.10% | 0.00% |
| Jan. 2, 2026 | Carter Robert Ross | Chief Financial Officer | S | Common Stock | 247 | $3.56 | 235,122.0000 | 99,303,511 | 0.10% | 0.00% |
| Dec. 15, 2025 | Hively Brad | Director | S | Common Stock | 13333 | $3.77 | 683,721.0000 | 99,303,511 | 1.91% | 0.01% |
| Nov. 20, 2025 | Johnson Karen Marie | Director | A | Common Stock | 37037 | $0.00 | 288,286.0000 | 99,303,511 | 14.74% | 0.04% |
| Nov. 20, 2025 | Pacala Mark L | Director | A | Common Stock | 46296 | $0.00 | 221,267.0000 | 99,303,511 | 26.46% | 0.05% |
| Nov. 20, 2025 | Pacala Mark L | Director | A | Common Stock | 35494 | $0.00 | 256,761.0000 | 99,303,511 | 16.04% | 0.04% |
| Nov. 20, 2025 | Hively Brad | Director | A | Common Stock | 41667 | $0.00 | 664,647.0000 | 99,303,511 | 6.69% | 0.04% |
| Nov. 20, 2025 | Hively Brad | Director | A | Common Stock | 32407 | $0.00 | 697,054.0000 | 99,303,511 | 4.88% | 0.03% |
| Nov. 20, 2025 | McGeorge Anne | Director | A | Common Stock | 67901 | $0.00 | 251,247.0000 | 99,303,511 | 37.03% | 0.07% |
| Nov. 20, 2025 | McGeorge Anne | Director | A | Common Stock | 40123 | $0.00 | 291,370.0000 | 99,303,511 | 15.97% | 0.04% |
| Nov. 20, 2025 | Kaushal Mohit | Director | A | Common Stock | 50926 | $0.00 | 228,179.0000 | 99,303,511 | 28.73% | 0.05% |
| Nov. 20, 2025 | Kaushal Mohit | Director | A | Common Stock | 40123 | $0.00 | 268,302.0000 | 99,303,511 | 17.58% | 0.04% |
| Nov. 20, 2025 | Ling Gabriel | Director | A | Common Stock | 46296 | $0.00 | 296,502.0000 | 99,303,511 | 18.50% | 0.05% |
| Nov. 20, 2025 | Ling Gabriel | Director | A | Common Stock | 37037 | $0.00 | 333,539.0000 | 99,303,511 | 12.49% | 0.04% |
| Nov. 20, 2025 | Johnson Karen Marie | Director | A | Common Stock | 47840 | $0.00 | 251,249.0000 | 99,303,511 | 23.52% | 0.05% |
| Nov. 18, 2025 | Pacala Mark L | Director | S | Common Stock | 2160 | $4.00 | 222,811.0000 | 99,303,511 | 0.96% | 0.00% |
| Nov. 18, 2025 | Pacala Mark L | Director | S | Common Stock | 46630 | $4.00 | 174,971.0000 | 99,303,511 | 21.04% | 0.05% |
| Nov. 18, 2025 | M33 Growth I L.P. | Director | J | Common Stock | 11818 | $0.00 | 7,944,207.0000 | 99,303,511 | 0.15% | 0.01% |
| Nov. 18, 2025 | M33 Growth I L.P. | Director | J | Common Stock | 2500000 | $0.00 | 5,444,207.0000 | 99,303,511 | 31.47% | 2.52% |
| Nov. 18, 2025 | M33 Growth I L.P. | Director | J | Common Stock | 590892 | $0.00 | 5,444,207.0000 | 99,303,511 | 9.79% | 0.60% |
| Nov. 18, 2025 | Ling Gabriel | Director | J | Common Stock | 141149 | $0.00 | 250,206.0000 | 99,303,511 | 129.43% | 0.14% |
| Nov. 18, 2025 | Pacala Mark L | Director | S | Common Stock | 1210 | $4.00 | 221,601.0000 | 99,303,511 | 0.54% | 0.00% |
| Nov. 17, 2025 | Podnos Yale | Chief Medical Officer | A | Common Stock | 2086 | $0.00 | 237,930.0000 | 99,303,511 | 0.88% | 0.00% |
| Nov. 17, 2025 | Virnich Daniel | Chief Executive Officer | A | Common Stock | 6464 | $0.00 | 1,799,984.0000 | 99,303,511 | 0.36% | 0.01% |
| Nov. 17, 2025 | Carter Robert Ross | Chief Financial Officer | A | Common Stock | 195 | $0.00 | 235,369.0000 | 99,303,511 | 0.08% | 0.00% |
| Nov. 12, 2025 | Podnos Yale | Chief Medical Officer | A | Common Stock | 306 | $0.00 | 234,642.0000 | 99,303,511 | 0.13% | 0.00% |
| Nov. 12, 2025 | Virnich Daniel | Chief Executive Officer | A | Common Stock | 6211 | $0.00 | 1,793,520.0000 | 99,303,511 | 0.35% | 0.01% |
| Nov. 12, 2025 | Podnos Yale | Chief Medical Officer | A | Common Stock | 1202 | $0.00 | 235,844.0000 | 99,303,511 | 0.51% | 0.00% |
| Sept. 4, 2025 | M33 Growth I L.P. | Director | S | Common Stock | 681832 | $3.09 | 8,523,281.0000 | 95,013,596 | 7.41% | 0.72% |
| Sept. 4, 2025 | M33 Growth I L.P. | Director | S | Common Stock | 6018168 | $3.09 | 8,523,281.0000 | 95,013,596 | 41.39% | 6.33% |
| Aug. 19, 2025 | Hively Brad | Director | S | Common stock | 20221 | $4.06 | 622,980.0000 | 95,013,596 | 3.14% | 0.02% |
| July 24, 2025 | BARASCH RICHARD A | Director | J | Common Stock | 287756 | $0.00 | 2,635,881.0000 | 95,013,596 | 9.84% | 0.30% |
| July 22, 2025 | England Kristin | Chief Administrative Officer | A | Common Stock | 98037 | $0.00 | 98,037.0000 | 95,013,596 | 9999.99% | 0.10% |
| June 17, 2025 | BARASCH RICHARD A | Director | X | Common Stock | 679224 | $1.20 | 3,234,765.0000 | 90,661,800 | 26.58% | 0.75% |
| June 17, 2025 | BARASCH RICHARD A | Director | F | Common Stock | 311128 | $2.62 | 2,923,637.0000 | 90,661,800 | 9.62% | 0.34% |
| June 17, 2025 | BARASCH RICHARD A | Director | X | Common Warrant | 679224 | $0.00 | 0.0000 | 90,661,800 | 100.00% | 0.75% |
| June 17, 2025 | BARASCH RICHARD A | Director | C | Class A Common Equivalent Preferred Stock | 1595 | $0.00 | 0.0000 | 90,661,800 | 100.00% | 0.00% |
| June 17, 2025 | BARASCH RICHARD A | Director | C | Common Stock | 159500 | $0.00 | 4,490,682.0000 | 90,661,800 | 3.68% | 0.18% |
| June 18, 2025 | BARASCH RICHARD A | Director | C | Common Stock | 620400 | $0.00 | 4,490,682.0000 | 90,661,800 | 16.03% | 0.68% |
| June 18, 2025 | BARASCH RICHARD A | Director | C | Class A Common Equivalent Preferred Stock | 6204 | $0.00 | 0.0000 | 90,661,800 | 100.00% | 0.01% |
| June 5, 2025 | M33 Growth I L.P. | Director | S | Common Stock | 76324 | $3.05 | 15,223,281.0000 | 90,661,800 | 0.50% | 0.08% |
| June 5, 2025 | M33 Growth I L.P. | Director | S | Common Stock | 673676 | $3.05 | 15,223,281.0000 | 90,661,800 | 4.24% | 0.74% |
| June 3, 2025 | Hively Brad | Director | M | Non-Qualified Stock Option (right to buy) | 131297 | $0.00 | 0.0000 | 90,661,800 | 0.00% | 0.14% |
| June 3, 2025 | Hively Brad | Director | M | Non-Qualified Stock Option (right to buy) | 946460 | $0.00 | 0.0000 | 90,661,800 | 0.00% | 1.04% |
| June 3, 2025 | Hively Brad | Director | M | Non-Qualified Stock Option (right to buy) | 684528 | $0.00 | 0.0000 | 90,661,800 | 0.00% | 0.76% |
| June 3, 2025 | Hively Brad | Director | M | Non-Qualified Stock Option (right to buy) | 105320 | $0.00 | 0.0000 | 90,661,800 | 0.00% | 0.12% |
| June 3, 2025 | Hively Brad | Director | M | Common Stock | 684528 | $0.85 | 1,396,561.0000 | 90,661,800 | 96.14% | 0.76% |
| June 3, 2025 | Hively Brad | Director | M | Common Stock | 105320 | $0.48 | 1,501,881.0000 | 90,661,800 | 7.54% | 0.12% |
| June 3, 2025 | Hively Brad | Director | M | Common Stock | 131297 | $1.87 | 1,633,178.0000 | 90,661,800 | 8.74% | 0.14% |
| June 3, 2025 | Hively Brad | Director | M | Common Stock | 946460 | $0.85 | 2,579,638.0000 | 90,661,800 | 57.95% | 1.04% |
| June 3, 2025 | Hively Brad | Director | S | Common Stock | 1867605 | $2.87 | 712,033.0000 | 90,661,800 | 72.40% | 2.06% |
| June 3, 2025 | Hively Brad | Director | S | Common Stock | 108532 | $2.87 | 603,501.0000 | 90,661,800 | 15.24% | 0.12% |
| May 21, 2025 | Langsam Jeffrey | Chief Clinical Officer | A | Common Stock | 57380 | $0.00 | 57,380.0000 | 90,661,800 | 9999.99% | 0.06% |
| May 21, 2025 | Castle Jeremy | Chief Operating Officer | D | Common stock | 5636 | $2.68 | 247,031.0000 | 90,661,800 | 2.23% | 0.01% |
| May 21, 2025 | Carter Robert Ross | Chief Financial Officer | D | Class A Common Stock | 1601 | $2.68 | 235,174.0000 | 90,661,800 | 0.68% | 0.00% |
| May 20, 2025 | M33 Growth I L.P. | Director | S | Common Stock | 203532 | $2.71 | 15,973,281.0000 | 90,661,800 | 1.26% | 0.22% |
| May 21, 2025 | Virnich Daniel | Chief Executive Officer | D | Common stock | 20388 | $2.68 | 1,787,309.0000 | 90,661,800 | 1.13% | 0.02% |
| May 21, 2025 | Podnos Yale | Chief Medical Officer | D | Common stock | 1801 | $2.68 | 234,336.0000 | 90,661,800 | 0.76% | 0.00% |
| May 20, 2025 | M33 Growth I L.P. | Director | S | Common Stock | 1796468 | $2.71 | 15,973,281.0000 | 90,661,800 | 10.11% | 1.98% |
| March 26, 2025 | Hively Brad | Director | P | Common Warrant | 22640 | $0.13 | 22,640.0000 | 77,470,886 | 9999.99% | 0.03% |
| March 26, 2025 | Hively Brad | Director | P | Common Stock | 45280 | $1.04 | 712,033.0000 | 77,470,886 | 6.79% | 0.06% |
| March 31, 2025 | Castle Jeremy | Chief Operating Officer | A | Common stock | 162281 | $0.00 | 252,667.0000 | 77,470,886 | 179.54% | 0.21% |
| March 31, 2025 | Podnos Yale | Chief Medical Officer | A | Common stock | 157088 | $0.00 | 236,137.0000 | 77,470,886 | 198.72% | 0.20% |
| March 31, 2025 | Virnich Daniel | Chief Executive Officer | A | Common stock | 1083334 | $0.00 | 1,807,697.0000 | 77,470,886 | 149.56% | 1.40% |
| March 31, 2025 | Carter Robert Ross | Chief Financial Officer | A | Class A Common Stock | 197368 | $0.00 | 236,775.0000 | 77,470,886 | 500.85% | 0.25% |
| March 26, 2025 | Virnich Daniel | Chief Executive Officer | P | Common Warrant | 11320 | $0.13 | 11,320.0000 | 77,470,886 | 9999.99% | 0.01% |
| March 26, 2025 | BARASCH RICHARD A | Director | P | Common Warrant | 679224 | $0.13 | 679,224.0000 | 77,470,886 | 9999.99% | 0.88% |
| March 26, 2025 | BARASCH RICHARD A | Director | P | Common Stock | 1358448 | $1.04 | 1,775,641.0000 | 77,470,886 | 325.62% | 1.75% |
| March 26, 2025 | Carter Robert Ross | Chief Financial Officer | P | Common Warrant | 4528 | $0.13 | 4,528.0000 | 77,470,886 | 9999.99% | 0.01% |
| March 26, 2025 | Carter Robert Ross | Chief Financial Officer | P | Common Stock | 9056 | $1.04 | 39,407.0000 | 77,470,886 | 29.84% | 0.01% |
| March 26, 2025 | Castle Jeremy | Chief Operating Officer | P | Common Warrant | 4528 | $0.13 | 4,528.0000 | 77,470,886 | 9999.99% | 0.01% |
| March 26, 2025 | Castle Jeremy | Chief Operating Officer | P | Common Stock | 9056 | $1.04 | 90,386.0000 | 77,470,886 | 11.13% | 0.01% |
| March 26, 2025 | Johnson Karen Marie | Director | P | Common Warrant | 18112 | $0.13 | 18,112.0000 | 77,470,886 | 9999.99% | 0.02% |
| March 26, 2025 | Johnson Karen Marie | Director | P | Common Stock | 36224 | $1.04 | 203,409.0000 | 77,470,886 | 21.67% | 0.05% |
| March 26, 2025 | Pacala Mark L | Director | P | Common Warrant | 42281 | $0.13 | 42,281.0000 | 77,470,886 | 9999.99% | 0.05% |
| March 26, 2025 | Pacala Mark L | Director | P | Common Stock | 90562 | $1.04 | 224,971.0000 | 77,470,886 | 67.38% | 0.12% |
| March 26, 2025 | Podnos Yale | Chief Medical Officer | P | Common Warrant | 4528 | $0.13 | 4,528.0000 | 77,470,886 | 9999.99% | 0.01% |
| March 26, 2025 | Podnos Yale | Chief Medical Officer | P | Common Stock | 9056 | $1.04 | 79,049.0000 | 77,470,886 | 12.94% | 0.01% |
| March 26, 2025 | Hively Brad | Director | P | Common Warrant | 4528 | $0.13 | 4,528.0000 | 77,470,886 | 9999.99% | 0.01% |
| March 26, 2025 | Hively Brad | Director | P | Common Stock | 9056 | $1.04 | 675,809.0000 | 77,470,886 | 1.36% | 0.01% |
| March 26, 2025 | Virnich Daniel | Chief Executive Officer | P | Common Stock | 22640 | $1.04 | 724,363.0000 | 77,470,886 | 3.23% | 0.03% |
| March 26, 2025 | M33 Growth I L.P. | Director | A | Warrant to Purchase Shares of Common Stock | 1358449 | $0.13 | 1,358,449.0000 | 77,470,886 | 9999.99% | 1.75% |
| March 26, 2025 | M33 Growth I L.P. | Director | A | Common Stock | 2716898 | $1.04 | 16,420,701.0000 | 77,470,886 | 19.83% | 3.51% |
| March 19, 2025 | Podnos Yale | Chief Medical Officer | D | Common stock | 2975 | $0.89 | 69,993.0000 | 77,470,886 | 4.08% | 0.00% |
| March 19, 2025 | Virnich Daniel | Chief Executive Officer | D | Common stock | 10261 | $0.89 | 701,723.0000 | 77,470,886 | 1.44% | 0.01% |
| March 19, 2025 | Carter Robert Ross | Chief Financial Officer | D | Class A Common Stock | 1150 | $0.89 | 30,351.0000 | 77,470,886 | 3.65% | 0.00% |
| Jan. 6, 2025 | Carter Robert Ross | Chief Financial Officer | D | Class A Common Stock | 258 | $0.34 | 31,501.0000 | 77,470,886 | 0.81% | 0.00% |
| Dec. 3, 2024 | Castle Jeremy | Chief Operating Officer | D | Common stock | 1130 | $0.16 | 81,330.0000 | 77,292,849 | 1.37% | 0.00% |
| Nov. 26, 2024 | Hively Brad | Director | P | Common stock | 250000 | $0.17 | 616,753.0000 | 77,292,849 | 68.17% | 0.32% |
| Nov. 12, 2024 | Hively Brad | Director | J | Common stock | 353450 | $0.00 | 366,753.0000 | 77,292,849 | 49.08% | 0.46% |
| Dec. 2, 2024 | Hively Brad | Director | P | Common stock | 50000 | $0.15 | 666,753.0000 | 77,292,849 | 8.11% | 0.06% |
| Nov. 22, 2024 | BARASCH RICHARD A | Director | A | Common stock | 80000 | $0.00 | 417,193.0000 | 77,292,849 | 23.73% | 0.10% |
| Nov. 22, 2024 | Ling Gabriel | Director | A | Common stock | 40000 | $0.00 | 109,057.0000 | 77,292,849 | 57.92% | 0.05% |
| Nov. 22, 2024 | Hively Brad | Director | A | Common stock | 44000 | $0.00 | 720,203.0000 | 77,292,849 | 6.51% | 0.06% |
| Nov. 22, 2024 | Kaushal Mohit | Director | A | Common stock | 56000 | $0.00 | 177,253.0000 | 77,292,849 | 46.18% | 0.07% |
| Nov. 22, 2024 | Johnson Karen Marie | Director | A | Common stock | 52000 | $0.00 | 167,185.0000 | 77,292,849 | 45.14% | 0.07% |
| Nov. 22, 2024 | McGeorge Anne | Director | A | Common stock | 56000 | $0.00 | 183,346.0000 | 77,292,849 | 43.97% | 0.07% |
| Nov. 22, 2024 | Pacala Mark L | Director | A | Common stock | 50000 | $0.00 | 134,409.0000 | 77,292,849 | 59.24% | 0.06% |
| Nov. 20, 2024 | Podnos Yale | Chief Medical Officer | D | Common stock | 1709 | $0.14 | 74,261.0000 | 77,292,849 | 2.25% | 0.00% |
| Nov. 20, 2024 | Virnich Daniel | Chief Executive Officer | D | Common stock | 4750 | $0.14 | 716,961.0000 | 77,292,849 | 0.66% | 0.01% |
| Nov. 20, 2024 | Virnich Daniel | Chief Executive Officer | D | Common stock | 4977 | $0.14 | 711,984.0000 | 77,292,849 | 0.69% | 0.01% |
| Nov. 20, 2024 | Carter Robert Ross | Chief Financial Officer | D | Class A Common Stock | 235 | $0.14 | 31,759.0000 | 77,292,849 | 0.73% | 0.00% |
| Nov. 20, 2024 | Podnos Yale | Chief Medical Officer | D | Common stock | 267 | $0.14 | 73,994.0000 | 77,292,849 | 0.36% | 0.00% |
| Nov. 20, 2024 | Podnos Yale | Chief Medical Officer | D | Common stock | 1026 | $0.14 | 72,968.0000 | 77,292,849 | 1.39% | 0.00% |
| Nov. 12, 2024 | Pacala Mark L | Director | J | Common stock | 20248 | $0.00 | 114,781.0000 | 77,292,849 | 15.00% | 0.03% |
| Nov. 12, 2024 | Virnich Daniel | Chief Executive Officer | J | Common stock | 117142 | $0.00 | 721,711.0000 | 77,292,849 | 13.96% | 0.15% |
| Nov. 12, 2024 | Virnich Daniel | Chief Executive Officer | J | Common stock | 78094 | $0.00 | 838,853.0000 | 77,292,849 | 8.52% | 0.10% |
| Nov. 12, 2024 | Pacala Mark L | Director | J | Common stock | 30372 | $0.00 | 84,409.0000 | 77,292,849 | 26.46% | 0.04% |
| Nov. 12, 2024 | Podnos Yale | Chief Medical Officer | J | Common stock | 11359 | $0.00 | 93,009.0000 | 77,292,849 | 10.88% | 0.01% |
| Nov. 12, 2024 | Podnos Yale | Chief Medical Officer | J | Common stock | 17039 | $0.00 | 75,970.0000 | 77,292,849 | 18.32% | 0.02% |
| Aug. 16, 2024 | Havencrest Healthcare Partners, L.P. | Not found | J | Common stock | 7631418 | $0.00 | 252,626.0000 | 77,224,263 | 96.80% | 9.88% |
| Aug. 16, 2024 | Havencrest Healthcare Partners, L.P. | Not found | J | Common stock | 8701823 | $0.00 | 7,884,044.0000 | 77,224,263 | 52.47% | 11.27% |
| June 17, 2024 | Hively Brad | Director | D | Common Stock | 18121 | $0.46 | 676,203.0000 | 76,046,694 | 2.61% | 0.02% |
| May 21, 2024 | Shah Mihir | Chief Financial Officer | A | Common Stock | 151459 | $0.00 | 474,931.0000 | 76,046,694 | 46.82% | 0.20% |
| May 21, 2024 | Podnos Yale | Chief Medical Officer | A | Common Stock | 17530 | $0.00 | 104,368.0000 | 76,046,694 | 20.19% | 0.02% |
| May 21, 2024 | Castle Jeremy | Chief Operating Officer | A | Non-Qualified Stock Option (right to buy) | 175299 | $0.00 | 175,299.0000 | 76,046,694 | 9999.99% | 0.23% |
| May 21, 2024 | Castle Jeremy | Chief Operating Officer | A | Common Stock | 70120 | $0.00 | 82,460.0000 | 76,046,694 | 568.23% | 0.09% |
| May 21, 2024 | Podnos Yale | Chief Medical Officer | A | Non-Qualified Stock Option (right to buy) | 43825 | $0.00 | 43,825.0000 | 76,046,694 | 9999.99% | 0.06% |
| May 22, 2024 | Hively Brad | Director | D | Common Stock | 19526 | $0.58 | 694,324.0000 | 76,046,694 | 2.74% | 0.03% |
| May 21, 2024 | Virnich Daniel | Chief Executive Officer | D | Common Stock | 11173 | $0.60 | 718,430.0000 | 76,046,694 | 1.53% | 0.01% |
| May 21, 2024 | Virnich Daniel | Chief Executive Officer | A | Common Stock | 198517 | $0.00 | 916,947.0000 | 76,046,694 | 27.63% | 0.26% |
| May 21, 2024 | Virnich Daniel | Chief Executive Officer | A | Non-Qualified Stock Option (right to buy) | 496293 | $0.00 | 496,293.0000 | 76,046,694 | 9999.99% | 0.65% |
| May 21, 2024 | Shah Mihir | Chief Financial Officer | A | Non-Qualified Stock Option (right to buy) | 378648 | $0.00 | 378,648.0000 | 76,046,694 | 9999.99% | 0.50% |
| Jan. 29, 2024 | Havencrest Healthcare Partners, L.P. | Not found | S | Common stock | 8637 | $2.12 | 8,801,823.0000 | 75,879,025 | 0.10% | 0.01% |
| Jan. 24, 2024 | Havencrest Healthcare Partners, L.P. | TenPercentOwner | S | Common stock | 24915 | $2.30 | 8,829,321.0000 | 75,879,025 | 0.28% | 0.03% |
| Jan. 25, 2024 | Havencrest Healthcare Partners, L.P. | TenPercentOwner | S | Common stock | 11882 | $2.07 | 8,817,439.0000 | 75,879,025 | 0.13% | 0.02% |
| Jan. 26, 2024 | Havencrest Healthcare Partners, L.P. | TenPercentOwner | S | Common stock | 6979 | $2.14 | 8,810,460.0000 | 75,879,025 | 0.08% | 0.01% |
| Jan. 19, 2024 | Havencrest Healthcare Partners, L.P. | TenPercentOwner | S | Common stock | 11986 | $2.13 | 8,869,837.0000 | 75,879,025 | 0.13% | 0.02% |
| Jan. 23, 2024 | Havencrest Healthcare Partners, L.P. | TenPercentOwner | S | Common stock | 5338 | $2.11 | 8,854,236.0000 | 75,879,025 | 0.06% | 0.01% |
| Jan. 22, 2024 | Havencrest Healthcare Partners, L.P. | TenPercentOwner | S | Common stock | 10263 | $2.12 | 8,859,574.0000 | 75,879,025 | 0.12% | 0.01% |
| Dec. 28, 2023 | Havencrest Healthcare Partners, L.P. | Not found | J | Common stock | 3999998 | $0.00 | 8,881,823.0000 | 73,265,621 | 31.05% | 5.46% |
| Dec. 28, 2023 | Havencrest Healthcare Partners, L.P. | Not found | J | Common stock | 4561050 | $0.00 | 12,801,821.0000 | 73,265,621 | 26.27% | 6.23% |
| Dec. 26, 2023 | BARASCH RICHARD A | Director | A | Common stock | 80000 | $0.00 | 337,201.0000 | 73,265,621 | 31.10% | 0.11% |
| Dec. 26, 2023 | Johnson Karen Marie | Director | A | Common stock | 52000 | $0.00 | 115,185.0000 | 73,265,621 | 82.30% | 0.07% |
| Dec. 26, 2023 | Hively Brad | Director | A | Common stock | 42652 | $0.00 | 713,850.0000 | 73,265,621 | 6.35% | 0.06% |
| Dec. 26, 2023 | Pacala Mark L | Director | A | Common stock | 46630 | $0.00 | 135,029.0000 | 73,265,621 | 52.75% | 0.06% |
| Dec. 26, 2023 | O'Meara Maeve | Director | A | Common stock | 50000 | $0.00 | 109,104.0000 | 73,265,621 | 84.60% | 0.07% |
| Dec. 26, 2023 | McGeorge Anne | Director | A | Common stock | 56000 | $0.00 | 127,346.0000 | 73,265,621 | 78.49% | 0.08% |
| Dec. 26, 2023 | Ling Gabriel | Director | A | Common stock | 40000 | $0.00 | 69,057.0000 | 73,265,621 | 137.66% | 0.05% |
| Dec. 26, 2023 | Kaushal Mohit | Director | A | Common stock | 53326 | $0.00 | 121,253.0000 | 73,265,621 | 78.50% | 0.07% |
| Dec. 14, 2023 | Shah Mihir | Chief Financial Officer | P | Common stock | 565 | $1.25 | 328,122.0000 | 73,265,621 | 0.17% | 0.00% |
| Dec. 14, 2023 | Shah Mihir | Chief Financial Officer | P | Common stock | 99435 | $1.27 | 327,557.0000 | 73,265,621 | 43.59% | 0.14% |
| Nov. 30, 2023 | Castle Jeremy | Chief Operating Officer | A | Non-Qualified Stock Option (right to buy) | 30849 | $0.00 | 30,849.0000 | 73,265,621 | 9999.99% | 0.04% |
| Nov. 30, 2023 | Castle Jeremy | Chief Operating Officer | A | Common stock | 12340 | $0.00 | 12,340.0000 | 73,265,621 | 9999.99% | 0.02% |
| Nov. 21, 2023 | Virnich Daniel | Chief Executive Officer | D | Common stock | 4322 | $2.19 | 729,603.0000 | 73,265,621 | 0.59% | 0.01% |
| Nov. 21, 2023 | Hively Brad | Director | D | Common stock | 25867 | $2.19 | 671,198.0000 | 73,265,621 | 3.71% | 0.04% |
| Nov. 21, 2023 | Podnos Yale | Chief Medical Officer | D | Common stock | 1530 | $2.19 | 86,838.0000 | 73,265,621 | 1.73% | 0.00% |
| Nov. 17, 2023 | Hively Brad | Director | M | Non-Qualified Stock Option (right to buy) | 25000 | $0.00 | 1,745,431.0000 | 73,265,621 | 1.41% | 0.03% |
| Nov. 17, 2023 | Hively Brad | Director | S | Common stock | 25000 | $2.24 | 697,065.0000 | 73,265,621 | 3.46% | 0.03% |
| Nov. 17, 2023 | Hively Brad | Director | M | Common stock | 25000 | $0.85 | 722,065.0000 | 73,265,621 | 3.59% | 0.03% |
| Nov. 14, 2023 | Podnos Yale | Chief Medical Officer | D | Common stock | 1860 | $2.39 | 88,368.0000 | 73,265,621 | 2.06% | 0.00% |
| Nov. 14, 2023 | Virnich Daniel | Chief Executive Officer | D | Common stock | 4604 | $2.39 | 733,925.0000 | 73,265,621 | 0.62% | 0.01% |
| Nov. 14, 2023 | Podnos Yale | Chief Medical Officer | D | Common stock | 238 | $2.39 | 90,228.0000 | 73,265,621 | 0.26% | 0.00% |
| Nov. 13, 2023 | Hively Brad | Director | S | Common stock | 47000 | $2.52 | 724,182.0000 | 73,265,621 | 6.09% | 0.06% |
| Nov. 13, 2023 | Hively Brad | Director | M | Common stock | 47000 | $0.85 | 771,182.0000 | 73,265,621 | 6.49% | 0.06% |
| Nov. 14, 2023 | Hively Brad | Director | D | Common stock | 27117 | $2.39 | 697,065.0000 | 73,265,621 | 3.74% | 0.04% |
| Nov. 13, 2023 | Hively Brad | Director | M | Non-Qualified Stock Option (right to buy) | 47000 | $0.00 | 1,770,431.0000 | 73,265,621 | 2.59% | 0.06% |
| May 23, 2023 | Shah Mihir | Chief Financial Officer | D | Common Stock | 869 | $0.43 | 223,472.0000 | 73,265,621 | 0.39% | 0.00% |
| May 23, 2023 | Shah Mihir | Chief Financial Officer | D | Common Stock | 2573 | $0.43 | 224,341.0000 | 73,265,621 | 1.13% | 0.00% |
| March 17, 2023 | Virnich Daniel | President | A | Common stock | 114944 | $0.00 | 738,529.0000 | 73,265,621 | 18.43% | 0.16% |
| March 17, 2023 | Virnich Daniel | President | A | Non-Qualified Stock Option (right to buy) | 287361 | $0.00 | 287,361.0000 | 73,265,621 | 9999.99% | 0.39% |
| March 17, 2023 | O'Meara Maeve | Director | A | Common stock | 16404 | $0.00 | 59,104.0000 | 73,265,621 | 38.42% | 0.02% |
| March 17, 2023 | McGeorge Anne | Director | A | Common stock | 26247 | $0.00 | 71,346.0000 | 73,265,621 | 58.20% | 0.04% |
| March 17, 2023 | Pacala Mark L | Director | A | Common stock | 6562 | $0.00 | 88,399.0000 | 73,265,621 | 8.02% | 0.01% |
| March 17, 2023 | Johnson Karen Marie | Director | A | Common stock | 19685 | $0.00 | 63,185.0000 | 73,265,621 | 45.25% | 0.03% |
| March 17, 2023 | Hively Brad | Chief Executive Officer | A | Common stock | 168512 | $0.00 | 724,182.0000 | 73,265,621 | 30.33% | 0.23% |
| March 17, 2023 | Hively Brad | Chief Executive Officer | A | Non-Qualified Stock Option (right to buy) | 421280 | $0.00 | 421,280.0000 | 73,265,621 | 9999.99% | 0.58% |
| March 17, 2023 | Miller Matthew P | Chief Operating Officer | A | Common stock | 67667 | $0.00 | 242,992.0000 | 73,265,621 | 38.60% | 0.09% |
| March 17, 2023 | Shah Mihir | Chief Financial Officer | A | Non-Qualified Stock Option (right to buy) | 440477 | $0.00 | 440,477.0000 | 73,265,621 | 9999.99% | 0.60% |
| March 17, 2023 | Shah Mihir | Chief Financial Officer | A | Common stock | 176191 | $0.00 | 226,914.0000 | 73,265,621 | 347.36% | 0.24% |
| March 17, 2023 | Miller Matthew P | Chief Operating Officer | A | Non-Qualified Stock Option (right to buy) | 169169 | $0.00 | 169,169.0000 | 73,265,621 | 9999.99% | 0.23% |
| March 17, 2023 | BARASCH RICHARD A | Director | P | Common stock | 10000 | $0.55 | 247,201.0000 | 73,265,621 | 4.22% | 0.01% |
| March 17, 2023 | BARASCH RICHARD A | Director | P | Common stock | 2146 | $0.55 | 237,201.0000 | 73,265,621 | 0.91% | 0.00% |
| March 17, 2023 | BARASCH RICHARD A | Director | P | Common stock | 7654 | $0.55 | 235,055.0000 | 73,265,621 | 3.37% | 0.01% |
| March 17, 2023 | BARASCH RICHARD A | Director | P | Common stock | 9948 | $0.55 | 227,401.0000 | 73,265,621 | 4.57% | 0.01% |
| March 17, 2023 | BARASCH RICHARD A | Director | P | Common stock | 200 | $0.55 | 217,453.0000 | 73,265,621 | 0.09% | 0.00% |
| March 17, 2023 | BARASCH RICHARD A | Director | P | Common stock | 52 | $0.55 | 217,253.0000 | 73,265,621 | 0.02% | 0.00% |
| March 17, 2023 | BARASCH RICHARD A | Director | P | Common stock | 10000 | $0.55 | 217,201.0000 | 73,265,621 | 4.83% | 0.01% |
| March 17, 2023 | Podnos Yale | Chief Medical Officer | A | Non-Qualified Stock Option (right to buy) | 83047 | $0.00 | 83,047.0000 | 73,265,621 | 9999.99% | 0.11% |
| March 17, 2023 | Podnos Yale | Chief Medical Officer | A | Common stock | 33219 | $0.00 | 90,466.0000 | 73,265,621 | 58.03% | 0.05% |
| March 17, 2023 | Kaushal Mohit | Director | A | Common stock | 19685 | $0.00 | 42,393.0000 | 73,265,621 | 86.69% | 0.03% |
| March 17, 2023 | BARASCH RICHARD A | Director | P | Common stock | 10000 | $0.55 | 257,201.0000 | 73,265,621 | 4.05% | 0.01% |
| March 17, 2023 | SARIN RAVI YANG | Director | A | Common stock | 29528 | $0.00 | 4,185,198.0000 | 73,265,621 | 0.71% | 0.04% |